LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $211,434 | +1.5% | 213,000 | 0.0% | 0.00% | – |
Q4 2022 | $208,386 | +0.7% | 213,000 | 0.0% | 0.00% | – |
Q3 2022 | $207,000 | +1492.3% | 213,000 | +1538.5% | 0.00% | – |
Q2 2022 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q1 2022 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | 0.0% | 13,000 | 0.0% | 0.00% | – |
Q3 2021 | $13,000 | -99.5% | 13,000 | -99.5% | 0.00% | -100.0% |
Q2 2021 | $2,727,000 | +156.5% | 2,763,000 | +166.7% | 0.00% | – |
Q1 2021 | $1,063,000 | -23.0% | 1,036,000 | -31.6% | 0.00% | – |
Q4 2020 | $1,380,000 | -35.2% | 1,515,000 | -35.5% | 0.00% | -100.0% |
Q3 2020 | $2,131,000 | +396.7% | 2,350,000 | +370.0% | 0.00% | – |
Q2 2020 | $429,000 | +10.0% | 500,000 | 0.0% | 0.00% | – |
Q1 2020 | $390,000 | -7.6% | 500,000 | 0.0% | 0.00% | – |
Q4 2019 | $422,000 | +1.2% | 500,000 | 0.0% | 0.00% | – |
Q3 2019 | $417,000 | -50.8% | 500,000 | -50.0% | 0.00% | – |
Q2 2019 | $847,000 | – | 1,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |